TransCode Therapeutics, Inc. (RNAZ)
NASDAQ: RNAZ · IEX Real-Time Price · USD
1.150
+0.265 (29.97%)
At close: May 17, 2024, 4:00 PM
1.170
+0.020 (1.74%)
After-hours: May 17, 2024, 7:59 PM EDT
TransCode Therapeutics Market Cap
TransCode Therapeutics has a market cap or net worth of $7.46 million as of May 17, 2024. Its market cap has increased by 62.11% in one year.
Market Cap
7.46M
Enterprise Value
2.88M
1-Year Change
62.11%
Ranking
Category
Stock Price
$1.15
Market Cap Chart
Since the IPO on July 9, 2021, TransCode Therapeutics's market cap has decreased from $47.87M to $7.46M, a decrease of -84.42%. That is a compound annual growth rate of -47.83%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 17, 2024 | 7.60M | 28.81% |
May 16, 2024 | 5.90M | 11.32% |
May 15, 2024 | 5.30M | 26.19% |
May 14, 2024 | 4.20M | 16.67% |
May 13, 2024 | 3.60M | -56.10% |
May 10, 2024 | 8.20M | 6.49% |
May 9, 2024 | 7.70M | 30.51% |
May 8, 2024 | 5.90M | -11.94% |
May 7, 2024 | 6.70M | 42.55% |
May 6, 2024 | 4.70M | -2.08% |
May 3, 2024 | 4.80M | 17.07% |
May 2, 2024 | 4.10M | 10.81% |
May 1, 2024 | 3.70M | 5.71% |
Apr 30, 2024 | 3.50M | 2.94% |
Apr 29, 2024 | 3.40M | 6.25% |
Apr 26, 2024 | 3.20M | 6.67% |
Apr 25, 2024 | 3.00M | 15.38% |
Apr 24, 2024 | 2.60M | -3.70% |
Apr 23, 2024 | 2.70M | - |
Apr 22, 2024 | 2.70M | -3.57% |
Apr 19, 2024 | 2.80M | -3.45% |
Apr 18, 2024 | 2.90M | - |
Apr 17, 2024 | 2.90M | - |
Apr 16, 2024 | 2.90M | -6.45% |
Apr 15, 2024 | 3.10M | -13.89% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Kintara Therapeutics | 7.81M |
Cyclerion Therapeutics | 7.72M |
Trevena | 7.68M |
NuCana | 7.54M |
XWELL | 7.53M |
Telesis Bio | 7.36M |
Vivos Therapeutics | 7.33M |
Hepion Pharmaceuticals | 7.25M |